This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ASM journals Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smee, D F Articles by Robins, R K Search for Related Content PubMed PubMed Citation Articles by Smee, D F Articles by Robins, R K

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1989 September; 33(9): 1487-1492

Broad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent.

D F Smee, H A Alaghamandan, H B Cottam, B S Sharma, W B Jolley and R K Robins

Nucleic Acid Research Institute, Costa Mesa, California 92626.

ABSTRACT

A novel immunopotentiating agent, 5-amino-3-beta-D-ribofuranosylthiazolo [4,5-d]pyrimidine-2,7(3H,6H)-dione (7-thia-8-oxoguanosine), lacks virus-inhibitory properties in vitro but induces interferon and potentiates immune functions, such as natural killer cell activity. It was evaluated in rodent models to determine the spectrum of antiviral activity and effective treatment regimens. At 50 to 200 mg/kg given as single or divided intraperitoneal (i.p.) doses 1 day before virus inoculation, significant protection was afforded to mice infected i.p. with Semliki Forest, San Angelo, banzi, and encephalomyocarditis viruses. Similarly, suckling rats were protected from an intranasal challenge with rat coronavirus. Against San Angelo virus, treatments could be delayed to 1 day post-virus inoculation and still show a beneficial effect. The compound was moderately effective in mice infected i.p. with herpes simplex virus type 2 or intranasally with vesicular stomatitis virus. No activity was seen against influenza B virus in mice when the analog was administered one time pre-virus inoculation or in multiple doses given before and after the virus inoculation. Nor was there a prophylactic effect against herpetic skin lesions on mice. This immune modulator may have promise for the treatment of a variety of virus infections.

---

Antimicrob Agents Chemother. 1989 September; 33(9): 1487-1492

This article has been cited by other articles:

• Lee, J., Wu, C. C. N., Lee, K. J., Chuang, T.-H., Katakura, K., Liu, Y.-T., Chan, M., Tawatao, R., Chung, M., Shen, C., Cottam, H. B., Lai, M. M. C., Raz, E., Carson, D. A. (2006). Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 103: 1828-1833 [Abstract] [Full Text]  
• Lee, J., Chuang, T.-H., Redecke, V., She, L., Pitha, P. M., Carson, D. A., Raz, E., Cottam, H. B. (2003). Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 100: 6646-6651 [Abstract] [Full Text]